Unique ID issued by UMIN | UMIN000003290 |
---|---|
Receipt number | R000003984 |
Scientific Title | A Study of the Antipruritic Effect and Onset of Sleepiness with Oral Antihistamines -Comparison of sedative and non-sedative antihistamine- |
Date of disclosure of the study information | 2010/03/05 |
Last modified on | 2011/04/21 17:45:34 |
A Study of the Antipruritic Effect and Onset of Sleepiness with Oral Antihistamines
-Comparison of sedative and non-sedative antihistamine-
A Study of the Antipruritic Effect and Onset of Sleepiness with Oral Antihistamines
A Study of the Antipruritic Effect and Onset of Sleepiness with Oral Antihistamines
-Comparison of sedative and non-sedative antihistamine-
A Study of the Antipruritic Effect and Onset of Sleepiness with Oral Antihistamines
Japan |
atopic dermatitis,chronic urticaria and pruritus
Dermatology |
Others
NO
Sedative and non-sedative antihistamines are to be administered in a crossover method to patients suffering from chronic skin diseases accompanied by atopic dermatitis, chronic urticaria, and pruritus to study the incidence and degree of sleepiness developing with each of the drugs. Efficacy against itching and efficacy against the primary disease will also be compared between drugs, along with QOL and drug safety.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Incidence and severity of sleepiness (JESS score)
1) NRS scoring for pruritus.
2) NRS scoring for sleepiness.
3) QOL with relation to skin diseases (Skindex-16).
4) Evaluation of severity of atopic dermatitis and evaluation of severity of pruritus in other skin diseases.
5) Safety
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Uncontrolled
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
Bepotastine besilate(14days),Wash out(7days) and d-Chlorpheniramine Maleate or Ketotifen(14days)
d-Chlorpheniramine Maleate or Ketotifen(14days),Wash out(7days) and Bepotastine besilate(14days)
16 | years-old | <= |
Not applicable |
Male and Female
1) Patients who were diagnosed with atopic dermatitis, chronic urticaria, and pruritus
2) Patients who were scored NRS 3<= for pruritus
3) Patients who gave their written informed consent
1)Patients who have the history of hypersensitivity to any of the study drug
2)Patients who had been taking an anti-histamine drug within 7 days before the registration
3)Patients who are pregnant,might be pregnant, lactating ,or wishing a pregnancy during the study period.
4)Patients who are complaining of sleepiness due to the influence of a regularly used drug that is not an antihistamine
5)Patients who are commonly complaining of intense sleepiness
6)Patients who are considered unsuitable for this study by the investigator
500
1st name | |
Middle name | |
Last name | Makoto Kawashima/Yoshiki Miyachi |
Tokyo Woman's Medical University/
Kyoto University Graduate School of Medicine
Dermatology/ Dermatology
8-1 Kawada-cho Shinjuku-ku, Tokyo 162-8666,Japan/54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
1st name | |
Middle name | |
Last name |
EBMs Co.,Ltd
Clinical Business Division
03-5777-1001
Tokyo Woman's Medical University
Non-Profit Organization Health Institute Research of Skin
Other
NO
2010 | Year | 03 | Month | 05 | Day |
Unpublished
Completed
2009 | Year | 11 | Month | 09 | Day |
2010 | Year | 01 | Month | 01 | Day |
2010 | Year | 12 | Month | 01 | Day |
2010 | Year | 03 | Month | 05 | Day |
2011 | Year | 04 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003984